Skip to main content
Fig. 1 | BMC Endocrine Disorders

Fig. 1

From: Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with newly onset diabetes following initiation of glucocorticoid treatment

Fig. 1

EANITIATE study design flow chart. SP = Sundhedsplatformen (Electronic patient records). A complete list of study sites can be obtained from the corresponding author

Back to article page